SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 In the present survey, 2.7 In the present survey, 2.7

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Cannabis Law Report

OCTOBER 15, 2019

As United Nations (UN) member states are set to meet in March 2019 to take stock of progress made since 2009 and delineate the next phase for global drug policy, this report evaluates the impacts of drug policies in Asia over the past decade from a civil society perspective. Copyright: International Drug Policy Consortium Publication 2019.

Policy 40

Policy Data Consumption Conditions 40

Cannabis Law Report

FEBRUARY 12, 2020

Over 1,000 patients have been treated since Emerald’s first clinic opened in December 2018, mostly for chronic non-cancer pain but also dozens of other conditions including side effects from chemotherapy, cancer pain and Alzheimer’s. In fiscal 2019 it had a loss of $5.5

Medicine 59

Medicine Data Patients Oil 59

CannaMD

NOVEMBER 4, 2020

The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. One 2019 study from The Journal of Pain found that people who had severe headaches and migraines were able to make them less painful by up to 50% after using cannabis. The study surveyed 9,885 Migraine Buddy users in the U.S.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Cannabis Law Report

JANUARY 23, 2022

I did not know what to expect and as well as presenting my first scientific poster, I was gaining my first taste of the academic world. But a few presentations from the week of presentations stood out to me. The grading of GVHD (Holler, Greinix and Zeiser, 2019). There were a lot of incredible memories built on that trip.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

CannaTech

MAY 16, 2019

CannaTech Tel Aviv 2019 was an absolute sensation, and we are already looking to Cape Town for our next big event. At this year’s CannaTech Tel Aviv we were completely blown away by the articulate presenters and innovative products being pitched. So, without further ado, let’s start with the winners: Kassi Labs.

Data 13

Data Collective Consumption Treatment 13

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

FEBRUARY 17, 2020

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. CANNABIS PRIMER. Glossary of Marijuana Terminologyvia CannaInsider.com. Americans for Safe Access.org.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

OCTOBER 4, 2021

Though the growing vegan population and cases of celiac disease will offer immense growth opportunities, the impact of natural disasters and adverse weather conditions, threat of substitutes, and product recalls and cross-contamination will challenge the growth of the market participants. Hemp-based Foods Market 2020-2024: Scope. Page number.

Food 52

Food Hemp Research and Development Data 52

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child.

Safety 116

Safety Patients Cannabis Law 116

The Joint Blog

JANUARY 23, 2020

.” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinical trials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. Dr. Johnson has also been presented with the prestigious Jack Mendelson Award from the NIAAA and the Solomon Carter Fuller Award by the American Psychiatric Association. Brinkley Smithers award from the American Association of Addiction Medicine. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 11, 2021

Since Thailand launched its first cannabis clinic in August 2019, the Public Health Ministry has opened over 500 more nationwide. Department records show that the health condition of 74% of patients improves after such treatment. At present, we have three formulas of cannabis oil. The first is Daycha Oil.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

MARCH 29, 2020

In fiscal 2019, the Curaleaf team delivered record results with our organic business growth and recent strategic acquisitions, solidifying our position as the leading cannabis operator in the United States,” CEO Joseph Lusardi said in a statement. Generated Record Fiscal Year 2019 Managed Revenue of $250.6 Q3 2019. % qoq Change.

Dispensary 59

Dispensary Research and Development Retail Cultivation 59

Cannabis Law Report

NOVEMBER 23, 2019

As of Tuesday, 277 out of the 407 permits involved had not received reinstatement to “active” status, according to state licensing data. Announces Third Quarter 2019 Results. . Nov 22, 2019, 07:00 ET . — Third quarter 2019 revenue of $14.1 ” 2019 Guidance (2). ” 2019 Guidance (2).

Legalization 59

Legalization Retail Research and Development Cultivation 59

Cannabis Law Report

JULY 30, 2019

Industry leaders have much to say, as well, as reported in Ruben Espinosa’s June 13, 2019 piece for Cannabis Business Executive , concerning whether or not the federal courts force cannabis out of the prohibitive Schedule I Class? In my estimation, the state’s overall program growth in Florida to date is impressive.

Marijuana 40

Marijuana Education Patients Research and Development 40

CannaMD

AUGUST 19, 2020

The CDC notes that individuals of all ages may contract COVID-19; however, the risk of death is significantly higher for older populations and those with underlying health conditions. 3) In 2019, researchers found that CBD reduced proinflammatory cytokine production, airway inflammation, and fibrosis in a mouse model of chronic asthma.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. July 22, 2019. Full report at. Full Letter. RE: 579289.

CBD 51

CBD Tincture Pets Chronic Pain 51

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients. Published 2019 May 6. Gardiner KM, Singleton JA, Sheridan J, Kyle GJ, Nissen LM.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MARCH 30, 2020

The onset of the COVID-19 outbreak presents a new arena of legal uncertainty for a rapidly expanding industry known to inhabit a constant state of flux. We want to be sure cardholders in the medical marijuana program can receive medication for one of 23 serious medical conditions during this difficult time.”.

Marijuana 59

Marijuana Dispensary Patients Business 59

Cannabis Law Report

FEBRUARY 17, 2022

The Commission continues to actively monitor the licensee’s compliance with the conditions of the Order including the licensee’s Standard Operating Procedures relative to product recalls and notification to the public. To date, no related illnesses have been reported to the Commission.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

FEBRUARY 22, 2019

The initial phase of this activity is aimed at determining and selecting three of more varieties of hybridized hemp strains identified by InPlanta for testing in the specific ecological conditions found in Cambodia. here’s the press release. Asia Cannabis Corp. Announces Execution of Agreement to Acquire Control of Cambodian Company.

Hemp 40

Hemp Research and Development Hybrid Strains 40

StrainConnect

APRIL 23, 2019

By Rachael Maddison with Bradley Slaughter • 24 Apr, 2019. However, terpene molecules are also present and provide hemp and cannabis with their unique aromas, such as floral, citrus, pine, and diesel. 2019, January 9). • 24 Apr, 2019. • 10 Mar, 2019. But these molecules are more than just a scent.

Terpenes 63

Terpenes Cannabinoids Therapy Hybrid 63

Cannabis Law Report

JANUARY 20, 2022

The transaction is expected to close in the second or third quarter of 2022, subject to customary closing conditions, including the receipt of regulatory approvals and approval by SPKB’s shareholders. Investor Presentation Information. Eleusis and Silver Spike have prepared a prerecorded investor presentation.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

NOVEMBER 22, 2019

Presenting Greenheart CBD – a company about to embark on a journey in an industry that is exploding. In Ireland, cannabis or hemp may be grown as a food product under the same conditions as EU regulations. In March 2019, the adventure expanded. However, these are not the usual crop that you would see growing in this country.

CBD 59

CBD Seed-To-Sale Extraction Oil 59

Cannabis Law Report

JUNE 2, 2022

Unsustainable pressure on supplies and shaky regulation and governance , coupled with seriously deepening drought conditions in some places due to climate change, along with drastic land-use change, have heightened the global water supply problem. An ever-present unseen illegal market complicates matters further. Zipper, S.

Legalization 52

Legalization Cultivation Cannabis Environment 52

Cannabis Law Report

JULY 8, 2021

According to data from the National Survey on Drug Use and Health, 44 percent of men and 35 percent of women had smoked marijuana at some point in their lives. According to data from the National Survey on Drug Use as well as Health6, the rate of previous cannabis use as well as number of customers were greater in 2009 (6.6 Conclusion.

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

AUGUST 12, 2019

August 9, 2019 9 min read. Since M&A activity in the cannabis business is relatively new, note that your M&A advisor may have to triangulate deals done in closely related industries until the valuation data builds up. This story originally appeared on Marijuana Venture. Source: [link]. Is your business special? Sure it is!

Business 40

Business Banking Cannabis Concentrates 40

The Blunt Truth

JUNE 18, 2020

million settlement, based on the actions of a third party texting technology, is insufficient, and who was at the same time hit with another separate TCPA suit based on their current terms and conditions. In April 2019, Eaze initially agreed to a $1.75 The Perfect Storm: TCPA + Cannabis Industry Factors. But Eaze is by no means alone.

Compliance 95

Compliance Compliance Data Dispensary 95

Veriheal

JANUARY 6, 2022

There have already been plenty of studies exploring psychedelics for various conditions, but they have all been limited by laws and strict regulations. million in 2019).” According to the National Institute on Mental Health, in 2019 there were an estimated 51.5 million Americans, 18 or older, who presented with AMI. .

Research and Development 52

Research and Development Data Conditions Treatment 52

Cannabis Law Report

AUGUST 30, 2019

The US Department of Agriculture (USDA) has released new data indicating a substantial increase in the growth of US hemp production. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking 45

Banking Research and Development Legislation Programs 45

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. The biggest pushback Phoenix has received until now has been the lack of data, Tindall said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

JUNE 9, 2021

The following is a tabular summary and commentary of revenue, gross profit, net income (loss) and net income (loss) per share for the three-month periods ended December 31, 2020 and September 30, 2020 as well as the twelve-month periods ended December 31, 2020 and December 31, 2019. ($ in millions, except per share amounts). million in 2019.

Retail 59

Retail Business Cultivation Events 59

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52